Attached files
file | filename |
---|---|
EX-10.1 - EX-10.1 - AIkido Pharma Inc. | a12-7845_1ex10d1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) March 5, 2012
Spherix Incorporated
(Exact name of registrant as specified in its charter)
(State or other jurisdiction |
|
(Commission |
|
(I.R.S. Employer |
Delaware |
|
0-5576 |
|
52-0849320 |
(Address of principal executive offices) |
|
(Zip Code) |
6430 Rockledge Drive, Suite 503, Bethesda, Maryland |
|
20817 |
Registrants telephone number, including area code 301-897-2540
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 1.01 Entry into a Material Definitive Agreement.
On March 5, 2012, the Company entered into an amendment to its office building lease, which extends the term of the lease five years. The lease as amended will expire on March 31, 2018.
Section 9 - Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits
Exhibits
10.1 Amendment to Office Building Lease, between Elizabethean Court Associates III Limited Partnership and the Company
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
Spherix Incorporated | |
|
|
(Registrant) | |
|
|
| |
|
|
By: | |
|
|
| |
|
|
/s/ Robert L. Clayton | |
|
|
Robert L. Clayton | |
|
|
CFO | |
|
|
| |
|
|
Date: |
March 23, 2012 |